Cochlear Implantation Among Adults and Older Children with Unilateral or Asymmetric Hearing Loss


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 13-009050
    NCT ID: NCT02105441
    Sponsor Protocol Number: 13-009050

About this study

Do adults and older children (greater than 7 years of age) with unilateral or assymetric hearing loss benefit from cochlear implantation on the worst hearing side.

This is not a funded study. All costs are billed through insurance for reimbursement. There is an insurance approval process that we move through after a participant has been evaluated at the Mayo Clinic and found to be a candidate for cochlear implantation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria


  • 18 years of age or older.
  • Hearing loss in the ear to be implanted must such that speech understanding is not possible with a well fitted hearing aid. Specifically, less than 50% monosyllabic word understanding when that ear is tested in the best-aided condition and the other ear is sufficiently occluded or masked.
  • Onset of hearing loss in the adult group must be post-lingual (after three years of age).


  • Children 7 years of age and older.
  • Hearing loss in the ear to be implanted configured such that word understanding is less 50% in the best aided condition.
  • Onset of hearing loss in the pediatric group must be post-lingual (after three years of age).

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Carlson, M.D.

Closed for enrollment

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions